Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.67ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.67ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.67EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.67EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.190EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.190EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.190ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.190ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.190EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.190EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.190ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.190ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.120EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.120EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.120ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.120ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.120EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.120EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.120ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.120ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.85EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.85ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.85ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.65EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.65ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.65ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.65EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.65EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.65ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.65ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BG.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BG.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BG.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BG.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BG.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BG.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.61EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used